These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 13815928)
1. Jaundice during treatment of myelomatosis with M & B 938. DENMAN AM; WARD HW Br Med J; 1960 Feb; 1(5171):482. PubMed ID: 13815928 [No Abstract] [Full Text] [Related]
2. The use of M and B 938 in myelomatosis. WARD HW J Fac Radiol; 1958 Oct; 9(4):221-2. PubMed ID: 24544992 [No Abstract] [Full Text] [Related]
4. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. VI. Metasarcolysin. AUSTIN C; BERGSAGEL DE; SPRAGUE CC Cancer Chemother Rep; 1962 Aug; 21():107-12. PubMed ID: 13863325 [No Abstract] [Full Text] [Related]
5. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. III. AB-100 (NSC-37095). BROWN CL; BERGSAGEL DE; LEVIN WC Cancer Chemother Rep; 1962 Aug; 21():81-5. PubMed ID: 13873596 [No Abstract] [Full Text] [Related]
6. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. I. Plan of study. BERGSAGEL DE; SPRAGUE CC; ROSS SW Cancer Chemother Rep; 1962 Aug; 21():69-74. PubMed ID: 13867795 [No Abstract] [Full Text] [Related]
7. [Experience with the use of sarcolysin in multiple myeloma]. ALEKSEEV GA; PETROV KIa Probl Gematol Pereliv Krovi; 1961 Dec; 6():3-10. PubMed ID: 13860267 [No Abstract] [Full Text] [Related]
8. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. II. Mitomycin C (NSC-26980). BERGSAGEL DE; ROSS SW; DAVIS P Cancer Chemother Rep; 1962 Aug; 21():75-80. PubMed ID: 13867793 [No Abstract] [Full Text] [Related]
9. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026). BERGSAGEL DE; ROSS SW; BAKER DT Cancer Chemother Rep; 1962 Aug; 21():101-6. PubMed ID: 13867792 [No Abstract] [Full Text] [Related]
10. Evaluation of new chemotherapeutic agents in treatment of multiple myeloma. VII. M & B 938. SKINNER W; BERGSAGEL DE; TRUAX W Cancer Chemother Rep; 1963 Apr; 28():13-5. PubMed ID: 13977908 [No Abstract] [Full Text] [Related]
11. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806). BERGSAGEL DE; SPRAGUE CC; AUSTIN C; GRIFFITH KM Cancer Chemother Rep; 1962 Aug; 21():87-99. PubMed ID: 13867794 [No Abstract] [Full Text] [Related]
13. [A contribution to the therapy of plasmocytoma]. PETRIDES P; MONCKE C Verh Dtsch Ges Inn Med; 1959; 65():211-4. PubMed ID: 14432305 [No Abstract] [Full Text] [Related]
14. Treatment of multiple myelomatosis with particular reference to radioactive iodine. Report of five cases. KAY HE; LEDLIE EM; SBRESNI RC Br J Radiol; 1959 Dec; 32():791-7. PubMed ID: 14404987 [No Abstract] [Full Text] [Related]
15. [On the treatment of myeloma]. GRIGOR'IANTS AN; VOLKOVA MA Sov Med; 1962 Jul; 26():20-3. PubMed ID: 13901909 [No Abstract] [Full Text] [Related]
16. A comparative study of optimal medical care with and without azaserine in multiple myeloma. HOLLAND JF Clin Pharmacol Ther; 1961; 2():22-8. PubMed ID: 13715278 [No Abstract] [Full Text] [Related]
17. [3 Cases of myelomic diseases treated with sarcolysin]. BELIAKOVA MM Sov Med; 1960 Feb; 24():62-5. PubMed ID: 13798452 [No Abstract] [Full Text] [Related]
18. [On the cytostatic therapy of plasmocytoma]. FASS H Med Monatsschr; 1962 Jun; 16():389-93. PubMed ID: 13891742 [No Abstract] [Full Text] [Related]
19. [Considerations on the therapy of plasmocytoma (on the basis of 6 personal cases]. CATTANEO I; ESPOSITO S Haematologica; 1959; 44():713-34. PubMed ID: 13808453 [No Abstract] [Full Text] [Related]
20. Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma. BERGSAGEL DE Cancer Chemother Rep; 1962 Feb; 16():261-66. PubMed ID: 13867796 [No Abstract] [Full Text] [Related] [Next] [New Search]